Jason Lampkin
👤 Speaker
406
total appearances
Appearances Over Time
Podcast Appearances
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance
If at the same time, you're beholden to price increases to make your plan...
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance
I worry for all but the best, it's too many daggers out.
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance
It's just being attacked from so many sides that it's hard.
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance
We just got used to these 130, 120% NRR years that were magical, that often didn't even rely on price increases, right?
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance
Slack never raised prices and still grew at 140% NRR.
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance
I don't know those days are ever coming back, no matter how good our agents are.